Dr. Schermerhorn's research interests include all aspects of diabetes mellitus in dogs and cats. Major diabetes-related projects currently underway in his laboratory include investigations into the cellular mechanisms of insulin secretion and the biochemistry of feline glucose metabolism. His clinical interests include canine and feline endocrinology, with a special emphasis on clinical aspects of diabetes, such as epidemiology, pathology, and therapeutic management. Selected Publications: Schermerhorn T, Sharp GWG. Norepinephrine acts on the KATP channel and produces different effects on [Ca2+]i in oscillating and non-oscillating HIT-T15 cells. Cell Calcium 27(3): 163-173, 2000. Schermerhorn T. Management of Insulin Overdose. Standards of Care: Emer and Crit Care Med. 3(11): 1-6, 2001. Schermerhorn T, Ewing SE. Persistent hyperglycemia in diabetic dogs and cats. Standards of Care: Emer and Crit Care Med. 3(11):7-14, 2001. Bratanova-Tochkova TK, Cheng H, Daniel S, Gunawardana S, Liu Y-J, Mulvaney-Musa J, Schermerhorn T, Straub SG, Yajima H, Sharp GWG. Triggering and augmentation mechanisms, granule pools and biphasic insulin secretion. Diabetes 51(Suppl 1):S83-S90, 2002. Toll J, Erb HN, Birnbaum N, Schermerhorn T. Prevalence and incidence of serum magnesium abnormalities in hospitalized cats. J Vet Intern Med. 16(3):217-221, 2002.
|
